Innoforce Pharmaceuticals

Manufacturer of biopharmaceuticals

placeHangzhou, Zhejiang, China calendar_todayFounded 2018 groups2 employees language innoforcepharma.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Operations & transport; filing pace accelerating. Cited 25 times.

YearFilings
20231
20243
20251

Investor mix

8 investors on record; lead investors include South China Venture Capital, Yanchuang Capital.

Investor typeCountShare
Venture capital450%
Private equity338%
Bank & private debt113%
Coming soon